dexcom glp-1 launches Dexcom One CGM in the UK Don't miss "In the News"
Description
Trending GLP-1s (like Ozempic) are now raising red flags for nAMD.
But their side effects often drive people to stop using them over the long term.
Our Loop Workforce Health Index data: 37.2% of urban professionals already show abnormal glucose metabolism
It can lead to weight loss, better glycemic control, and reduced cardiometabolic risk factors
New data from 333,000 patients: 3 years on: 18% risk of heart attack, stroke, death Stop at 12 months: +14% risk Stop at 18 months: benefit fully erased Stop at 24 months: +22% risk It takes 3 years to build it
[ = ] 2023 GLP-1 '(
